ATE285765T1 - Kapsel, enthaltend ein dioxabicyclo(3.3.0)oktan - Google Patents

Kapsel, enthaltend ein dioxabicyclo(3.3.0)oktan

Info

Publication number
ATE285765T1
ATE285765T1 AT97112931T AT97112931T ATE285765T1 AT E285765 T1 ATE285765 T1 AT E285765T1 AT 97112931 T AT97112931 T AT 97112931T AT 97112931 T AT97112931 T AT 97112931T AT E285765 T1 ATE285765 T1 AT E285765T1
Authority
AT
Austria
Prior art keywords
sup
octane
dioxabicyclo
methoxy
methylenedioxyphenyl
Prior art date
Application number
AT97112931T
Other languages
English (en)
Inventor
Yoshifumi Shinmen
Kengo Akimoto
Sumio Asami
Yoshihide Suwa
Yoshinori Kitagawa
Michihiro Sugano
Hideaki Yamada
Sakayu Shimizu
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP1187497A external-priority patent/JP3001589B2/ja
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of ATE285765T1 publication Critical patent/ATE285765T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A23D7/0056Spread compositions
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/60Salad dressings; Mayonnaise; Ketchup
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Finger-Pressure Massage (AREA)
  • Cosmetics (AREA)
  • Fats And Perfumes (AREA)
AT97112931T 1989-07-21 1990-07-20 Kapsel, enthaltend ein dioxabicyclo(3.3.0)oktan ATE285765T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1187497A JP3001589B2 (ja) 1989-07-21 1989-07-21 リグナン類含有飲食物
JP8750090 1990-04-03

Publications (1)

Publication Number Publication Date
ATE285765T1 true ATE285765T1 (de) 2005-01-15

Family

ID=26428763

Family Applications (3)

Application Number Title Priority Date Filing Date
AT90307978T ATE208195T1 (de) 1989-07-21 1990-07-20 Mittel zur verbesserung der leberfunktion
AT97112930T ATE241978T1 (de) 1989-07-21 1990-07-20 Therapeutische anwendung von dioxabicyclo(3.3.0)oktan-verbindungen
AT97112931T ATE285765T1 (de) 1989-07-21 1990-07-20 Kapsel, enthaltend ein dioxabicyclo(3.3.0)oktan

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AT90307978T ATE208195T1 (de) 1989-07-21 1990-07-20 Mittel zur verbesserung der leberfunktion
AT97112930T ATE241978T1 (de) 1989-07-21 1990-07-20 Therapeutische anwendung von dioxabicyclo(3.3.0)oktan-verbindungen

Country Status (8)

Country Link
US (1) US5180588A (de)
EP (3) EP0826369B1 (de)
AT (3) ATE208195T1 (de)
CA (2) CA2021714C (de)
DE (3) DE69033848T2 (de)
DK (3) DK0826369T3 (de)
ES (3) ES2235205T3 (de)
SG (1) SG42967A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3183664B2 (ja) * 1990-10-22 2001-07-09 サントリー株式会社 コレステロール及び胆汁酸の代謝阻害剤
JP3283274B2 (ja) * 1991-06-15 2002-05-20 サントリー株式会社 新規組成物
US20020031563A1 (en) * 1992-09-30 2002-03-14 Hodge Thomas W. Method of inhibiting tumor necrosis factor
US5397778A (en) * 1994-02-25 1995-03-14 New England Deaconess Hospital Corporation Enteral formulations for treatment of inflammation and infection
AU1928295A (en) * 1994-02-25 1995-09-11 New England Deaconess Hospital Corporation Anti-inflammatory and infection protective effects of sesamin-based lignans
JP3818680B2 (ja) * 1994-05-12 2006-09-06 サントリー株式会社 アレルギー症状の予防又は改善剤
JPH08268887A (ja) * 1995-02-01 1996-10-15 Suntory Ltd 高血圧症又はそれに起因する医学的症状の予防又は改善剤
AU716372C (en) * 1995-07-04 2001-07-26 Suntory Holdings Limited Food composition containing an omega-6/omega-3 unsaturated fatty acid balance modifier
FR2738828B1 (fr) * 1995-09-20 1997-10-17 Commissariat Energie Atomique Utilisation de cyclodextrines naturelles et de leurs derives pour la solubilisation d'agents anti-agregants plaquettaires de la famille des ginkgolides
US5993795A (en) * 1995-11-09 1999-11-30 Takemoto Yushi Kabushiki Kaisha Protein composition derived from sesame seed and use thereof
US5811313A (en) * 1997-06-17 1998-09-22 King Pharmaceuticals, Inc. Identification test for highly refined sesame oil
EP1435984A1 (de) * 2001-10-19 2004-07-14 Maxim Pharmaceuticals, Inc. Verwendung von histamin zur behandlung von lebererkrankungen
JP4388248B2 (ja) * 2001-10-29 2009-12-24 株式会社日立製作所 最適ポートフォリオ決定方法および装置
FI114917B (fi) * 2002-08-29 2005-01-31 Hormos Nutraceutical Oy Ltd Lignaanikomplekseja
SG158183A1 (en) * 2004-12-28 2010-01-29 Suntory Holdings Ltd Sesamin/episesamin compositions
US8685455B2 (en) * 2005-03-31 2014-04-01 Suntory Holdings Limited Oil-in-water emulsions containing lignan-class compounds and compositions containing the same
JP5091680B2 (ja) 2005-09-30 2012-12-05 サントリーホールディングス株式会社 エピセサミン高含有組成物の製造方法及び装置
US20090054443A1 (en) * 2006-03-15 2009-02-26 Suntory Limited Compositions containing riboflavin and sesamin-class compounds
JP5069416B2 (ja) * 2006-03-15 2012-11-07 サントリーホールディングス株式会社 吸湿性の改善された飲食品用組成物
SG172594A1 (en) 2006-03-31 2011-07-28 Suntory Holdings Ltd Jp Compositions containing lignan-class compounds
CA2680751C (en) * 2007-03-15 2016-01-26 Suntory Holdings Limited Use of dioxabicyclo[3.3.0]octane derivatives as anti-fatigue agents
CN101801370B (zh) * 2007-09-19 2013-06-12 三得利控股株式会社 含有芝麻素类和花生四烯酸类的组合物
US8703789B2 (en) * 2007-09-19 2014-04-22 Suntory Holdings Limited Compositions incorporating sesamin-class compounds and vitamin B1 class compounds
JP6156795B2 (ja) * 2013-07-05 2017-07-05 公立大学法人大阪市立大学 脂肪細胞分化の抑制用、脂肪細胞の脂肪蓄積量低減用および/または脂肪細胞のアディポネクチン分泌促進用組成物
CN104804012B (zh) * 2015-04-24 2017-06-30 沈阳药科大学 一种具有抗耐药菌活性的化合物止泻木脂素a及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4427694A (en) * 1982-06-11 1984-01-24 The Vinoxen Company, Inc. Sesamin as a psychotropic agent
KR880701234A (ko) * 1986-06-13 1988-07-26 쓰무라 아끼라 신규 비페닐 유도체와 그의 제조 방법 및 용도
JPH01135892A (ja) * 1987-11-20 1989-05-29 Kuki Sangyo Kk 抗酸化性物質の製造方法
US4868207A (en) * 1988-07-28 1989-09-19 Taisho Pharmaceutical Co., Ltd. Bis (methylenedioxy) biphenyl compounds useful for the treatment of liver diseases
JP3070611B2 (ja) * 1989-03-07 2000-07-31 サントリー株式会社 △▲上5▼―不飽和化酵素阻害剤
JPH02255616A (ja) * 1989-03-27 1990-10-16 Rooman Kogyo:Kk 肝臓疾患用剤

Also Published As

Publication number Publication date
EP0409654A2 (de) 1991-01-23
SG42967A1 (en) 1997-10-17
DE69034084T2 (de) 2003-12-04
EP0826369A1 (de) 1998-03-04
CA2172855C (en) 2000-02-15
DK0409654T3 (da) 2001-12-27
DE69034084D1 (de) 2003-07-10
ES2235205T3 (es) 2005-07-01
ES2161680T3 (es) 2001-12-16
EP0409654A3 (en) 1992-05-27
DE69033848T2 (de) 2002-04-04
DE69033848D1 (de) 2001-12-13
EP0826369B1 (de) 2003-06-04
ATE241978T1 (de) 2003-06-15
ES2195058T3 (es) 2003-12-01
DK0826369T3 (da) 2003-09-29
US5180588A (en) 1993-01-19
CA2172855A1 (en) 1991-01-22
DE69034181D1 (de) 2005-02-03
DK0818196T3 (da) 2005-05-02
ATE208195T1 (de) 2001-11-15
EP0409654B1 (de) 2001-11-07
EP0818196A1 (de) 1998-01-14
CA2021714A1 (en) 1991-01-22
DE69034181T2 (de) 2006-01-26
EP0818196B1 (de) 2004-12-29
CA2021714C (en) 1996-07-23

Similar Documents

Publication Publication Date Title
ATE285765T1 (de) Kapsel, enthaltend ein dioxabicyclo(3.3.0)oktan
ES2072387T3 (es) Medicamento para el tratamiento de trombo, inflamacion y presion sanguinea alta.
KR850000402A (ko) 카르보스티릴 유도체의 제조방법
IL77452A0 (en) Derivatives of arylcyclobutylalkylamines,their preparation and pharmaceutical compositions containing them
EP0340754A3 (de) Monopersulfate von Amino-(poly)percarbonsäuren
EP0488513A3 (de) Verwendung von Dioxabicyclo [3.3.0]octane Derivaten zur Herstellung eines Arzneimittels zur Hemmung des Cholesterinmetabolismus.
WO1999030722A8 (en) Pharmaceutical compositions for mucolysis and treatment of inflammation
AU578395B2 (en) Antiallergic 5-alkyl-1-phenyl-2-piperazinoalkyl-pyrazoline- 3-one compounds
ES2008962A6 (es) Proceso para la preparacion de nuevos compuestos de 2-guanidinotiazol
EP0374838A3 (de) Elektrophotographische Elemente, die bestimmte Anthrachinonderivate als Elektronenübertragungsmittel enthalten
EP0681788A3 (de) Dioxabicyclo 3.3.0 octan-Derivate, z.B. Sesamin etc., zur Vorbeugung und Erleichterung von Allergiesymptomen
IL78273A0 (en) (4.2.0)bicyclooctane derivatives,their preparation and pharmaceutical compositions containing them
ATE21695T1 (de) Aminocyclopentanester, ihre herstellung und pharmazeutische formulierungen.
EP0204148A3 (de) [1,4]Benzodioxin- und [1,4]Benzoxazinderivate
JPS5287171A (en) Gamma-pyrone, gamma-pyridone compounds, preparation and medicines consisting of them
JPS527953A (en) Preparation of novel methano-anthracene derivatives
EP0304842A3 (de) Isoprenderivate und diese enthaltende Anti-Ulcus-Mittel
AU2891195A (en) Novel 4-substituted 2,6-di-tert-butylphenol compounds, pharmaceutical compositions containing same and preparation method therefor
JPS5328177A (en) Optical active piperidine derivatives and their preparation
JPS56122372A (en) Prostaglandin i2 derivative
JPS6452771A (en) Amino-containing 1,3-dithian compound and insecticidal and acaricidal composition containing said compound
JPS5430151A (en) 3-hydroxy-2-cyclohexene-1-one derivatives and their preparation
JPS5325514A (en) Omega,omega-bis(alkylthio)-or omega,omega-(alkylenedithio)-2,5-dioxoalkane and its preparation
SE8600411D0 (sv) Isokinolinderivat, deras framstellning och anvendning
IL90172A0 (en) 2,3-dihydro-imidazo(1,2-a)furo and-thieno pyridine derivatives,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0818196

Country of ref document: EP

EELA Cancelled due to lapse of time